Iris Nagtegaal
Overview
Explore the profile of Iris Nagtegaal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
1538
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Exploring nurses' leadership and resilience in a complex daily work environment: a qualitative study
Lenssen E, Nagtegaal I, van Oostveen C, Sieben A, van Rijssen L, Weggelaar A
BMC Nurs
. 2025 Feb;
24(1):173.
PMID: 39953459
Background: The contemporary healthcare system is inherently complex, necessitating organizational and ward-level changes to address challenges. Continuous adaptations in daily practices are essential to meet unexpected patient needs. These dynamic...
2.
Vink-Borger E, Knijn N, de Bruine A, Stavast J, van der Post R, Nagtegaal I
Histopathology
. 2024 Dec;
86(5):805-812.
PMID: 39648952
Aim: The term 'intramucosal carcinoma' in the colorectum is controversial when used as a synonym for high-grade dysplasia. However, setting clear definitions for this diagnosis (i.e. unequivocal infiltrative growth in...
3.
Fiegl A, Wendler O, Giedl J, Gaisa N, Richter G, Campean V, et al.
Curr Oncol
. 2024 Oct;
31(10):5752-5761.
PMID: 39451731
Penile squamous cell carcinoma (pSCC) is a rare malignancy with a global incidence ranging from 0.1 to 0.7 per 100,000 males. Prognosis is generally favorable for localized tumors, but metastatic...
4.
Vink-Borger E, den Bakker M, Voorham R, van Nederveen F, Nagtegaal I
Histopathology
. 2024 Jun;
85(4):639-648.
PMID: 38859771
Aims: Traditionally, mismatch repair (MMR) status is determined by a panel of four antibodies (MLH1, PMS2, MSH2, MSH6). If all proteins are retained, cases are MMR proficient (pMMR), while loss...
5.
Zaffaroni G, Mannucci A, Koskenvuo L, de Lacy B, Maffioli A, Bisseling T, et al.
Br J Surg
. 2024 May;
111(5).
PMID: 38722804
Background: Hereditary adenomatous polyposis syndromes, including familial adenomatous polyposis and other rare adenomatous polyposis syndromes, increase the lifetime risk of colorectal and other cancers. Methods: A team of 38 experts...
6.
Aherne S, Donnelly M, Ryan E, Davey M, Creavin B, McGrath E, et al.
Histopathology
. 2024 Apr;
85(2):224-243.
PMID: 38629323
Background: Tumour budding (TB) is a marker of tumour aggressiveness which, when measured in rectal cancer resection specimens, predicts worse outcomes and response to neoadjuvant therapy. We investigated the utility...
7.
Rolleman N, Klein W, Nagtegaal I, van Putten M, de Blaauw I, Botden S
Sci Rep
. 2024 Feb;
14(1):3585.
PMID: 38351192
Current diagnostics in Hirschsprung's disease are often challenging and invasive. This study aims to investigate whether surface electroenterography can non-invasively discern healthy subjects from subjects suffering from Hirschsprung's disease. Nine...
8.
Kooyker A, de Jonge L, Toes-Zoutendijk E, Spaander M, van Vuuren H, Kuipers E, et al.
Clin Gastroenterol Hepatol
. 2023 Aug;
21(13):3424-3432.e2.
PMID: 37619823
Background & Aims: For colorectal cancer (CRC) screening to be effective, it is important that screen-detected cancers are found at an early stage. Studies on stage distribution of screen-detected CRC...
9.
Khan A, Brouwer N, Blank A, Muller F, Soldini D, Noske A, et al.
Mod Pathol
. 2023 Feb;
36(5):100118.
PMID: 36805793
Screening of lymph node metastases in colorectal cancer (CRC) can be a cumbersome task, but it is amenable to artificial intelligence (AI)-assisted diagnostic solution. Here, we propose a deep learning-based...
10.
Te Groen M, Derks M, den Broeder N, Peters C, Dijkstra G, de Vries A, et al.
Clin Gastroenterol Hepatol
. 2022 Dec;
22(2):357-367.e5.
PMID: 36572110
Background And Aims: Although colorectal cancer (CRC) surveillance is embedded in clinical inflammatory bowel disease (IBD) practice, a subset of patients still develops advanced neoplasia (AN) (high-grade dysplasia [HGD] and/or...